If you work in pharmaceutical manufacturing, quality assurance, or regulatory affairs, you have almost certainly encountered both “GMP” and “cGMP” — sometimes in the same sentence. Most people use them interchangeably, but there is an important and meaningful distinction between the two.
Understanding the difference between GMP and cGMP — and knowing where EU GMP fits in — is essential for anyone responsible for compliance, training, or audit readiness in a regulated manufacturing environment.
This guide explains exactly what each term means, how they differ in practice, and what it means for your training and compliance obligations.
What is GMP (Good Manufacturing Practices)?
GMP stands for Good Manufacturing Practices. It refers to the system of quality regulations and guidelines that govern how pharmaceutical products, biologics, active pharmaceutical ingredients (APIs), and medical devices are manufactured, tested, and controlled.
GMP ensures that every batch of a medicinal product is:
- Consistently manufactured to a defined quality standard
- Fit for its intended use
- Compliant with the requirements of the marketing authorisation or product specification
- Free from contamination, mix-ups, and errors that could harm patients
GMP covers every aspect of production — from raw material sourcing and facility design, to personnel training, equipment qualification, in-process controls, and finished product testing.
The foundations of GMP were first formalised in the United States following the thalidomide tragedy of the late 1950s and early 1960s, which caused thousands of birth defects across Europe. In response, the US Congress passed the Kefauver-Harris Drug Amendments Act of 1962, mandating that drug manufacturers prove not only that their products were safe, but that they were manufactured under rigorous quality controls.
The FDA issued its first formal GMP regulations — 21 CFR Part 133 — in 1963, which were later expanded and updated into the current 21 CFR Parts 210 and 211, which remain the core US GMP framework today.
What is cGMP (Current Good Manufacturing Practices)?
cGMP stands for current Good Manufacturing Practices. It is the same regulatory framework as GMP — but the addition of the word “current” carries significant meaning.
When the FDA added the “c” to GMP, it was making a deliberate point: manufacturers must not simply meet the minimum standards written in regulations from decades past. They must use the most up-to-date technologies, processes, systems, and scientific understanding available to ensure product quality.
In the FDA’s own words:
“The ‘c’ in cGMP stands for current, requiring companies to use technologies and systems that are up-to-date in order to comply with the regulations. Systems and equipment that may have been ‘top of the line’ 20 years ago may be less than adequate by today’s standards.”
This means cGMP is a living, evolving standard. What constituted acceptable manufacturing practice in 1980 may not be acceptable today. A manufacturer cannot argue that their outdated processes are compliant simply because they met the standards when they were first installed.
Practical examples of the “current” requirement:
| Area | Old GMP Approach | cGMP (Current) Approach |
| Data recording | Paper batch records | Electronic batch records with audit trails (21 CFR Part 11) |
| Environmental monitoring | Manual, periodic sampling | Continuous automated environmental monitoring systems |
| Process control | Operator-dependent manual controls | Process Analytical Technology (PAT) and automated controls |
| Equipment cleaning | Manual cleaning with visual inspection | Validated cleaning procedures with analytical verification |
| Training records | Paper logbooks | Electronic training management systems |
The “c” in cGMP is not just a prefix — it is a compliance obligation that requires continuous investment in improvement and modernisation.
GMP vs cGMP — Key Differences at a Glance
| Feature | GMP | cGMP |
| Full name | Good Manufacturing Practices | Current Good Manufacturing Practices |
| Used by | Global industry (general term) | US FDA specifically; widely adopted globally |
| Regulatory basis | General quality principles | FDA 21 CFR Parts 210 & 211; requires current technology |
| Scope | Broad quality standards | Same as GMP + obligation to use current best practices |
| Technology requirement | Not explicitly mandated | Must use current, up-to-date systems and technologies |
| Data integrity | Documentation required | Electronic records and 21 CFR Part 11 compliance expected |
| Enforcement | Varies by jurisdiction | FDA inspections, Warning Letters, Import Alerts, consent decrees |
| Primary market | Global | United States (FDA-regulated facilities worldwide) |
What is EU GMP — And How Does It Differ?
While the FDA uses the term cGMP, the European Medicines Agency (EMA) governs pharmaceutical manufacturing in Europe through EU GMP, codified in EudraLex Volume 4 — the Pharmaceutical Legislation for medicinal products for human and veterinary use.
EU GMP is structured around a set of Parts and Annexes:
- Part I — Basic requirements for medicinal products
- Part II — Basic requirements for active substances (APIs) used as starting materials
- Part III — GMP-related documents (ICH guidelines, Q&As)
- Annexes — Specific guidance for particular manufacturing operations (e.g., Annex 1 for sterile products, Annex 11 for computerised systems, Annex 15 for qualification and validation)
GMP vs cGMP vs EU GMP — Side-by-Side Comparison
| Feature | GMP (general) | cGMP (FDA) | EU GMP (EMA) |
| Governing authority | International / generic | US FDA | European Medicines Agency |
| Core regulation | Various | 21 CFR Parts 210 & 211 | EudraLex Volume 4 |
| API manufacturing | ICH Q7 | 21 CFR Part 211 / ICH Q7 | EudraLex Part II / ICH Q7 |
| Sterile manufacturing | Varies | 21 CFR Part 211 Subpart D | EU GMP Annex 1 (revised 2022) |
| Computer systems | Varies | 21 CFR Part 11 | EU GMP Annex 11 |
| Qualified Person (QP) | Not required | Not required | Mandatory — QP must certify each batch |
| Annual Product Review | Varies | Required (Product Quality Review) | Required |
| Technology requirement | Not explicit | “Current” technology required | Technology-neutral but modernisation expected |
| Market | Global (general) | US market | EU / European Economic Area |
Key practical difference — the Qualified Person (QP)
One of the most significant differences between FDA cGMP and EU GMP is the Qualified Person (QP) requirement. Under EU GMP, every manufacturing authorisation holder must have at least one QP — a named individual with specific educational and professional qualifications — who is personally responsible for certifying that each batch of medicine complies with GMP and the relevant marketing authorisation before it is released to the market.
The FDA does not have an equivalent QP requirement. Instead, the FDA uses a system of Quality Control Unit (QCU) oversight — a department or group with authority to approve or reject materials, components, and products.
Why Does the Distinction Matter?
For most pharmaceutical professionals working in a GMP-regulated environment, the practical day-to-day requirements of cGMP and EU GMP are very similar. However, the distinction matters enormously in three specific situations:
1. Regulatory submissions and inspections
If your facility manufactures for the US market, the FDA will inspect against cGMP standards — and will specifically look for evidence that you are using current best practices. Outdated systems, paper-based data management, and lack of electronic audit trails are common FDA 483 observations and warning letter topics.
If your facility manufactures for the EU market, you must comply with EudraLex Volume 4 and must have a QP in place.
2. Training and certification
cGMP training must cover not only the core regulatory requirements but also the current expectations — including 21 CFR Part 11 for electronic records, data integrity requirements, and Process Analytical Technology (PAT) where applicable.
EU GMP training must cover EudraLex Volume 4, including the relevant Annexes for your specific manufacturing operations.
3. Dual-market manufacturers
Many pharmaceutical facilities manufacture for both the US and EU markets simultaneously. These sites must understand where FDA cGMP and EU GMP align — and where they diverge — to maintain compliance with both regulatory frameworks at the same time.
Who Needs cGMP Training?
cGMP training is a regulatory requirement for all personnel whose work directly or indirectly affects the quality of a medicinal product manufactured for the US market.
Roles that require cGMP training:
Manufacturing & Production
- Production operators and technicians
- Manufacturing supervisors and managers
- Process engineers and validation engineers
Quality
- Quality Assurance (QA) specialists and managers
- Quality Control (QC) analysts and laboratory scientists
- Regulatory Affairs professionals
- Qualified Persons (EU facilities)
Engineering & Facilities
- Facilities engineers and maintenance technicians
- Instrumentation and calibration specialists
- Utilities managers (HVAC, water systems, clean steam)
Supply Chain
- Raw material procurement and supplier qualification teams
- Warehouse and storage operations managers
When is cGMP training required?
- On joining a pharmaceutical manufacturing organisation
- When job responsibilities change — any new role that affects product quality
- When regulations are updated — e.g., FDA guidance on data integrity or new Annex 1 requirements
- Annually — most organisations require annual GMP refresher training as a minimum
- Before an FDA inspection or EMA audit — to ensure all personnel are current on requirements
GMP Requirements by Sector
GMP and cGMP requirements vary depending on what is being manufactured. The key regulatory frameworks by sector are:
| Sector | US (FDA) | EU (EMA) | International (ICH/WHO) |
| Finished pharmaceuticals | 21 CFR Part 211 | EudraLex Volume 4, Part I | WHO GMP |
| API manufacturing | 21 CFR Part 211 / ICH Q7 | EudraLex Part II / ICH Q7 | ICH Q7 |
| Biological products | 21 CFR Parts 600–680 | EudraLex Annex 2 | WHO GMP for biologicals |
| Medical devices | 21 CFR Part 820 (QSR/QMSR) | EU MDR 2017/745 | ISO 13485 |
| Veterinary medicines | 21 CFR Part 211 | EudraLex Volume 4 (veterinary) | WHO GMP |
| Sterile products | 21 CFR Part 211 Subpart D | EU GMP Annex 1 (2022 revision) | WHO GMP for sterile pharma |
How to Get GMP / cGMP Certified Online
Structured online GMP training is the most efficient way for pharmaceutical professionals to meet their training obligations and earn a verifiable compliance certificate. Here is how to do it:
Step 1 — Choose the right course for your market
- If you manufacture for the US market, choose a course that covers FDA 21 CFR Parts 210 and 211, data integrity, and 21 CFR Part 11.
- If you manufacture for the EU market, choose a course covering EudraLex Volume 4 and the relevant Annexes.
- If you manufacture for both, or for emerging markets, choose a course that covers both FDA and EMA frameworks — plus WHO and ICH alignment.
Step 2 — Complete the course modules at your own pace
A comprehensive GMP course should cover:
- Regulatory background and the history of GMP
- Core GMP principles — documentation, personnel, facilities, equipment, QC
- Data integrity and 21 CFR Part 11 / Annex 11
- GMP for APIs (ICH Q7)
- Common GMP deficiencies and FDA 483 observations
- Practical exercises and case studies
Step 3 — Pass the assessment and download your certificate
On successful completion, download your 21 CFR Part 11 compliant digital certificate. This can be used as evidence of training during FDA inspections, EMA audits, and internal compliance reviews.
Step 4 — Schedule annual refresher training
GMP requirements evolve. The revised Annex 1 for sterile products came into effect in August 2023. New FDA guidance on data integrity is regularly issued. Schedule annual refresher training to stay current.
Frequently Asked Questions
Is GMP the same as cGMP?
They refer to the same regulatory framework, but cGMP specifically includes the obligation to use current, up-to-date technologies and systems. The FDA uses “cGMP”; other regulatory bodies (EMA, WHO) typically use “GMP.” In practice, they are used interchangeably in the industry.
What does the “c” stand for in cGMP?
“c” stands for “current.” It means manufacturers must use the latest technologies, systems, and best practices — not just the minimum standards that were acceptable years ago.
Is EU GMP the same as cGMP?
Both are GMP frameworks, but they are issued by different regulatory authorities (FDA vs EMA) and have some important differences — including the EU requirement for a Qualified Person (QP) to certify each batch before release.
Do I need separate training for GMP and cGMP?
No — a well-designed GMP training course will cover both FDA cGMP requirements and the “current” expectations including data integrity and electronic systems. There is no separate cGMP course; cGMP is GMP plus the obligation to stay current.
What is 21 CFR Part 211?
21 CFR Part 211 is the core FDA regulation for cGMP in the manufacture of finished pharmaceutical products. It covers organisation and personnel, buildings and facilities, equipment, control of components, production and process controls, packaging and labelling, laboratory controls, and records and reports.
How often should GMP training be renewed?
Most pharmaceutical companies require annual GMP refresher training as a minimum. Training should also be updated whenever there are significant regulatory changes, new guidances, or changes to an employee’s role.
What happens if a company fails cGMP compliance?
Consequences range from FDA Form 483 observations during inspection, to Warning Letters published publicly, to Import Alerts (stopping products from entering the US market), to consent decrees requiring FDA-supervised remediation. Severe cases can result in product recalls and facility shutdowns.
Conclusion
GMP and cGMP are not two different sets of regulations — they are the same framework, with cGMP carrying the additional and important obligation to use current, up-to-date manufacturing practices and technologies. EU GMP covers the same fundamental principles but is governed by the EMA and has some important structural differences, including the mandatory Qualified Person requirement.
For pharmaceutical manufacturers, the practical implication is clear: you must not only know the regulations — you must keep pace with evolving expectations, updated guidances, and current industry standards. That is what “current” in cGMP demands.
Structured GMP training aligned with FDA 21 CFR Parts 210 and 211, EudraLex Volume 4, and ICH Q7 gives you and your team the knowledge and documented evidence of competency required for inspection readiness.
Ready to get GMP certified?
Our online GMP training course covers FDA cGMP, EU GMP (EMA), ICH Q7, and data integrity requirements — all in one comprehensive, self-paced programme. 19 modules. Industry-recognised certificate. 21 CFR Part 11 compliant.
👉 Enroll in GMP Training — $399
Also explore:
